RVPH: Reviva Pharmaceuticals Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 38.12
Enterprise Value ($M) 32.65
Book Value ($M) -9.98
Book Value / Share -0.30
Price / Book -3.82
NCAV ($M) -10.80
NCAV / Share -0.32
Price / NCAV -3.53

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -6.13
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.39
Current Ratio 0.39

Balance Sheet (mrq) ($M)
Current Assets 6.81
Assets 7.63
Liabilities 17.61
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Armistice Capital, Llc 9.99 90.36
11-14 13G Schonfeld Strategic Advisors LLC 5.30
08-23 13D/A Bhat Laxminarayan 8.60 0.29
08-23 13D/A Saxena Parag 16.90
08-14 13G Integrated Core Strategies (us) Llc 5.20
05-31 13D/A Vedanta Partners, Llc 18.50 -2.39
02-14 13G/A Tang Capital Partners Lp 9.99 36.73

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-29 81,789 268,487 30.46
2024-11-27 173,606 539,679 32.17
2024-11-26 108,992 443,244 24.59
2024-11-25 35,531 411,768 8.63

(click for more detail)

Similar Companies
RMTI – Rockwell Medical, Inc. RNAZ – TransCode Therapeutics, Inc.
RNXT – RenovoRx, Inc. RZLT – Rezolute, Inc.
SABS – SAB Biotherapeutics, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.